NCT00113542View on ClinicalTrials.gov

A Study of Tetrathiomolybdate in the Treatment of Psoriasis Vulgaris

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 30, 2004

Study Completion Date

June 30, 2005

Conditions
Psoriasis
Interventions
DRUG

Tetrathiomolybdate (TM)

Trial Locations (1)

48109

University of Michigan Department of Dermatology, Ann Arbor

All Listed Sponsors
lead

University of Michigan

OTHER

NCT00113542 - A Study of Tetrathiomolybdate in the Treatment of Psoriasis Vulgaris | Biotech Hunter | Biotech Hunter